I tre kliniske optrapningsforsøg sås en effekt allerede ved en daglig dosis på 1, 1 mg base (1, 5 mg salt).
During dose escalation in three pivotal studies, efficacy was observed starting at a daily dose of 1.1 mg of base (1.5 mg of salt).